Celsee, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2015, the company has rapidly established itself as a leader in single-cell analysis, focusing on innovative solutions that enhance research and clinical applications. Celsee's flagship products, including the Celsee® System, are designed to streamline the isolation and analysis of single cells, offering unparalleled precision and efficiency. This unique approach positions Celsee at the forefront of advancements in personalised medicine and cancer research. With a commitment to transforming the landscape of cellular analysis, Celsee, Inc. has garnered recognition for its cutting-edge technology and has achieved notable milestones in the field, solidifying its reputation as a trusted partner for researchers and clinicians alike.
How does Celsee, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Celsee, Inc.'s score of 35 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Celsee, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a merged entity, inheriting emissions data from its parent organisation, Bio-Rad Laboratories, Inc. However, no specific emissions figures or reduction targets have been disclosed. Celsee, Inc. has not outlined any specific climate commitments or reduction initiatives, nor does it appear to have set Science-Based Targets (SBTi) for emissions reduction. The absence of detailed emissions data and climate pledges suggests that the company may still be in the early stages of developing its sustainability strategy. As part of the broader industry context, companies like Celsee, Inc. are increasingly expected to adopt transparent climate commitments and set measurable targets to reduce their carbon footprint. This trend is driven by growing regulatory pressures and stakeholder expectations for corporate responsibility in addressing climate change.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 18,420,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 13,615,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 314,454,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Celsee, Inc.'s Scope 3 emissions, which decreased by 26% last year and decreased by approximately 6% since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 85% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Celsee, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.